iShares U.S. Healthcare ETF News - October 2026
Humana Soars 15% on 2027 Ratings, With 95% in 4+ Star Plans
Humana shares rose more than 15% in premarket trading after the insurer reported a sharp improvement in its Medicare Advantage (MA) Star Ratings for the 2027...
Eli Lilly reports EloraTZP's 23.3% average weight loss in Phase 2
Eli Lilly reported positive Phase 2 results for EloraTZP, its next-generation obesity drug. Patients taking the drug lost an average of 23.3% of their body...
Eli Lilly's Oral Foundayo Shows Cardiovascular Safety in Largest Diabetes Trial
Eli Lilly said its oral GLP-1 drug Foundayo demonstrated cardiovascular non-inferiority in the largest diabetes trial conducted to date. Cardiovascular safety...